Multifunctional hydrophobin: Toward functional coatings for drug nanoparticles

ACS Nano

Volumn 4, Issue 3, 2010, Pages 1750-1758

  Valo, Hanna K ^a   Laaksonen, Päivi H ^b   Peltonen, Leena J ^a   Linder, Markus B ^b   Hirvonen, Jouni T ^a   Laaksonen, Timo J ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

^b VTT TECHNICAL RESEARCH CENTRE OF FINLAND   (Finland)

Author keywords

Beclomethasone dipropionate; Functionalization; Fusion proteins; Hydrophobins; Labeling; Nanoparticles

Indexed keywords

COATED NANOPARTICLES; DRUG FORMULATIONS; DRUG NANOPARTICLES; FUNCTIONAL COATING; FUNCTIONAL SITES; FUNCTIONAL SURFACES; FUNCTIONALIZATIONS; FUNCTIONALIZED; FUSION PROTEINS; GREEN FLUORESCENT PROTEIN; HYDROPHOBINS; LIPOPHILIC DRUGS; NANO-SIZED; PHARMACEUTICAL TECHNOLOGIES; RAPID DEVELOPMENT; SUBMICROMETERS; SURFACE CHARACTER; SURFACE LAYERS;

BIOCHEMISTRY; DRUG INTERACTIONS; DRUG PRODUCTS; LABELING; NANOPARTICLES; PROTECTIVE COATINGS; PROTEINS; SURFACE PROPERTIES; SUSPENSIONS (FLUIDS);

CONTROLLED DRUG DELIVERY;

ALLERGEN; BECLOMETASONE; DRUG; DRUG CARRIER; FUNGAL PROTEIN; FUNGUS ANTIGEN; HCH 1 PROTEIN, CLADOSPORIUM HERBARUM; HCH-1 PROTEIN, CLADOSPORIUM HERBARUM; NANOPARTICLE; PROTEIN;

ADSORPTION; ARTICLE; CHEMISTRY; GENETICS; METABOLISM; PROTEIN ENGINEERING; SOLUBILITY; TRANSMISSION ELECTRON MICROSCOPY;

ADSORPTION; ALLERGENS; ANTIGENS, FUNGAL; BECLOMETHASONE; DRUG CARRIERS; FUNGAL PROTEINS; MICROSCOPY, ELECTRON, TRANSMISSION; NANOPARTICLES; PHARMACEUTICAL PREPARATIONS; PROTEIN ENGINEERING; PROTEINS; SOLUBILITY;

EID: 77950150687     PISSN: 19360851     EISSN: 1936086X     Source Type: Journal    
DOI: 10.1021/nn9017558     Document Type: Article

References (51)

1. Hillaireau, H.; Couvreur, P. Nanocarriers' Entry into the Cell: Relevance to Drug Delivery. Cell. Mol. Life. Sci. 2009, 66, 2873-2896.
2. Peltonen, L.; Hirvonen, J. Physicochemical Characterization of Nano- and Microparticles. Curr. Nanosci. 2008, 4, 101-107.
3. Marcucci, F.; Lefoulon, F. Active Targeting with Particulate Drug Carriers in Tumor Therapy: Fundamentals and Recent Progress. Drug Discovery Today 2004, 9, 219-228.
4. Müller, R. H.; Peters, K. Nanosuspensions for the Formulation of Poorly Soluble Drugs: I. Preparation by a Size-Reduction Technique. Int. J. Pharm. 1998, 160, 229-237.
5. Bilati, U.; Allémann, E.; Doelker, E. Development of a Nanoprecipitation Method Intended for the Entrapment of Hydrophilic Drugs into Nanoparticles. Eur. J. Pharm. Sci. 2005, 24, 67-75.
6. Wang, Z.; Chen, J.; Le, Y.; Shen, Z.; Yun, J. Preparation of Ultrafine Beclomethasone Dipropionate Drug Powder by Antisolvent Precipitation. Ind. Eng. Chem. Res. 2007, 46, 4839-4845.
7. Keck, C. M.; Müller, R. H. Drug Nanocrystals of Poorly Soluble Drugs Produced by High Pressure Homogenisation. Eur. J. Pharm. Biopharm. 2006, 26, 3-16.
8. Matteucci, M. E.; Hotze, M. A.; Johnston, K. P.; Williams, R. O. Drug Nanoparticles by Antisolvent Precipitation: Mixing Energy versus Surfactant Stabilization. Langmuir 2006, 22, 8951-8959.
9. Galindo-Rodriguez, S.; Allémann, E.; Fessi, H.; Doelker, E. Physicochemical Parameters Associated with Nanoparticle Formation in the Salting-out, Emulsification-Diffusion, and Nanoprecipitation Methods. Pharm. Res. 2004, 21, 1428-1439.
10. Patravale, V. B.; Date, A. A.; Kulkarni, M. R. Nanosuspensions: A Promising Drug Delivery Strategy. J. Pharm. Pharmacol. 2004, 56, 827-840.
11. Torchilin, V. P. Polymer-Coated Long-Circulating Microparticulate Pharmaceuticals. J. Microencapsulation 1998, 15, 1-19.
12. Bae, Y. H. Drug Targeting and Tumor Heterogeneity. J. Controlled Release 2009, 133, 2-3.
13. Couvreur, P.; Gref, R.; Andrieux, K.; Malvy, C. Nanotechnologies for Drug Delivery: Application to Cancer and Autoimmune Diseases. Prog. Solid State Chem. 2006, 34, 231-235.
14. Linder, M. B. Hydrophobins: Proteins That Self Assemble at Interfaces. Curr. Opin. Colloid Interface Sci. 2009, 14, 356-363.
15. Linder, M.; Selber, K.; Nakari-Setala, T.; Qiao, M.; Kula, M.; Penttila, M. The Hydrophobins HFBI and HFBII from Trichoderma reesei Showing Efficient Interactions with Nonionic Surfactants in Aqueous Two-Phase Systems. Biomacromolecules 2001, 2, 511-517.
16. Wessels, J. G. H. Developmental Regulation of Fungal Cell Wall Formation. Annu. Rev. Phytopathol. 1994, 32, 413-437.
17. Linder, M. B.; Szilvay, G. R.; Nakari-Setälä, T.; Penttilä, M. E. Hydrophobins: The Protein-Amphiphiles of Filamentous Fungi. FEMS Microbiol. Rev. 2005, 29, 877-896.
18. Wösten, H. A. B. Hydrophobins: Multipurpose Proteins. Annu. Rev. Microbiol. 2001, 55, 625-646.
19. Nakari-Setälä, T.; Aro, N.; Ilmén, M.; Muñoz, G.; Kalkkinen, N.; Penttilä, M. Differential Expression of the Vegetative and Spore-Bound Hydrophobins of Trichoderma reesei. Eur. J. Biochem. 1997, 248, 415-423.
20. de Vocht, M. L.; Scholtmeijer, K.; van der Vegte, E. W.; de Vries, O. M. H.; Sonveaux, N.; Wösten, H. A. B.; Ruysschaert, J.; Hadziioannou, G.; Wessels, J. G. H.; Robillard, G. T. Structural Characterization of the Hydrophobin SC3, as a Monomer and after Self-Assembly at Hydrophobic/Hydrophilic Interfaces. Biophys. J. 1998, 74, 2059-2068.
21. Ebbole, D. J. Hydrophobins and Fungal Infection of Plants and Animals. Trends Microbiol. 1997, 5, 405-408.
22. Aimanianda, V.; Bayry, J.; Bozza, S.; Kniemeyer, O.; Perruccio, K.; Elluru, S. R.; Clavaud, C.; Paris, S.; Brakhage, A. A.; Kaveri, S. V.; et al. Surface Hydrophobin Prevents Immune Recognition of Airborne Fungal Spores. Nature 2009, 460, 1117-1121.
23. Linder, M.; Szilvay, G. R.; Nakari-Setälä, T.; Söderlund, H.; Penttilä, M. Surface Adhesion of Fusion Proteins Containing the Hydrophobins HFBI and HFBII from Trichoderma reesei. Protein Sci. 2002, 11, 2257-2266.
24. Torkkeli, M.; Serimaa, R.; Ikkala, O.; Linder, M. Aggregation and Self-Assembly of Hydrophobins from Trichoderma reesei: Low-Resolution Structural Models. Biophys. J. 2002, 83, 2240-2247.
25. Laaksonen, P.; Kivioja, J.; Paananen, A.; Kainlauri, M.; Kontturi, K.; Ahopelto, J.; Linder, M. B. Selective Nanopatterning Using Citrate-Stabilized Au Nanoparticles and Cystein-Modified Amphiphilic Protein. Langmuir 2009, 25, 5185-5192.
26. Haas Jimoh Akanbi, M.; Post, E.; Meter-Arkema, A.; Rink, R.; Robillard, G. T.; Wang, X.; Wösten, H. A. B.; Scholtmeijer, K. Use of Hydrophobins in Formulation of Water Insoluble Drugs for Oral Administration. Colloids Surf., B 2009, 75, 526-531.
27. Lumsdon, S. O.; Green, J.; Stieglitz, B. Adsorption of Hydrophobin Proteins at Hydrophobic and Hydrophilic Interfaces. Colloid Surf., B 2005, 44, 172-178.
28. Janssen, M. I.; van Leeuwen, M. B. M.; Scholtmeijer, K.; van Kooten, T. G.; Dijkhuizen, L.; Wösten, H. A. B. Coating with Genetic Engineered Hydrophobin Promotes Growth of Fibroblasts on a Hydrophobic Solid. Biomaterials 2002, 23, 4847-4854.
29. Scholtmeijer, K.; Janssen, M. I.; Gerssen, B.; de Vocht, M. L.; van Leeuwen, B. M.; van Kooten, T. G.; Woesten, H. A. B.; Wessels, J. G. H. Surface Modifications Created by Using Engineered Hydrophobins. Appl. Environ. Microbiol. 2002, 68, 1367-1373.
30. De Stefano, L.; Rea, I.; Armenante, A.; Giardina, P.; Giocondo, M.; Rendina, I. Self-Assembled Biofilm of Hydrophobins Protects the Silicon Surface in the KOH Wet Etch Process. Langmuir 2007, 23, 7920-7922.
31. Sarlin, T.; Nakari-Setala, T.; Linder, M.; Penttila, M.; Haikara, A. Fungal Hydrophobins as Predictors of the Gushing Activity of Malt. J. Inst. Brew. 2005, 111, 105-111.
32. Cox, A. R.; Aldred, D. L.; Russell, A. B. Exceptional Stability of Food Foams Using Class II Hydrophobin HFBII. Food Hydrocolloids 2009, 23, 366-376.
33. Hektor, H.; Scholtmeijer, K. Hydrophobins: Proteins with Potential. Curr. Opin. Biotechnol. 2005, 16, 434-439.
34. Rogers, T. L.; Gillespie, I. B.; Hitt, J. E.; Fransen, K. L.; Crowl, C. A.; Tucker, C. J.; Kupperblatt, G. B.; Becker, J. N.; Wilson, D. L.; Todd, C.; et al. Development and Characterization of a Scalable Controlled Precipitation Process to Enhance the Dissolution of Poorly Water-Soluble Drugs. Pharm. Res. 2004, 21, 2048-2057.
35. Rasenack, N.; Steckel, H.; Müller, B. W. Micronization of Anti-Inflammatory Drugs for Pulmonary Delivery by a Controlled Crystallization Process. J. Pharm. Sci. 2003, 92, 35-44.
36. Zimmermann, A.; Millqvist-Fureby, A.; Elema, M. R.; Hansen, T.; Müllertz, A.; Hovgaard, L. Adsorption of Pharmaceutical Excipients onto Microcrystals of Siramesine Hydrochloride: Effects on Physicochemical Properties. Eur. J. Pharm. Biopharm. 2009, 71, 109-116.
37. Zhang, H.; Wang, J.; Zhang, Z.; Le, Y.; Shen, Z.; Chen, J. Micronization of Atorvastatin Calcium by Antisolvent Precipitation Process. Int. J. Pharm. 2009, 374, 106-113.
38. Park, K.; Lee, M.; Hwang, K.; Kim, C. Phospholipid-Based Microemulsions of Flurbiprofen by the Spontaneous Emulsification Process. Int. J. Pharm. 1999, 183, 145-154.
39. Lim, S.; Kim, C. Formulation Parameters Determining the Physicochemical Characteristics of Solid Lipid Nanoparticles Loaded with All-Trans Retinoic Acid. Int. J. Pharm. 2002, 243, 135-146.
40. Cox, A. R.; Cagnol, F.; Russell, A. B.; Izzard, M. J. Surface Properties of Class II Hydrophobins from Trichoderma reesei and Influence on Bubble Stability. Langmuir 2007, 23, 7995-8002.
41. Abdelwahed, W.; Degobert, G.; Stainmesse, S.; Fessi, H. Freeze-Drying of Nanoparticles: Formulation, Process and Storage Considerations. Adv. Drug Delivery Rev. 2006, 58, 1688-1713.
42. Safaei, A.; Attarian Shandiz, M. Size-Dependent Thermal Stability and the Smallest Nanocrystal. Phys. E 2009, 41, 359-364.
43. Wen, Y.; Fang, H.; Zhu, Z.; Sun, S. Molecular Dynamics Investigation of Shape Effects on Thermal Characteristics of Platinum Nanoparticles. Phys. Lett. A 2009, 373, 272-276.
44. Eerikäinen, H.; Kauppinen, E. I. Preparation of Polymeric Nanoparticles Containing Corticosteroid by a Novel Aerosol Flow Reactor Method. Int. J. Pharm. 2003, 263, 69-83.
45. Yiyun, C.; Jiepin, Y. Solubilization of Non-Steroidal Anti-Inflammatory Drugs in the Presence of Tween Series Surfactants. Phys. Chem. Liq. 2006, 44, 249-256.
46. Nelson, K. G. Kelvin Equation and Solubility of Small Particles. J. Pharm. Sci. 1972, 61, 479-480.
47. Cao, Y.; Wang, Z.; Jin, X.; Hua, X.; Liu, M.; Zhao, Y. Preparation of Au Nanoparticles-Coated Polystyrene Beads and Its Application in Protein Immobilization. Colloids Surf., A 2009, 334, 53-58.
48. Ghosh, P.; Han, G.; De, M.; Kim, C. K.; Rotello, V. M. Gold Nanoparticles in Delivery Applications. Adv. Drug Delivery Rev. 2008, 60, 1307-1315.
49. Lin, Y.; Yu, B.; Lin, W.; Lee, S.; Kuo, C.; Shyue, J. Tailoring the Surface Potential of Gold Nanoparticles with Self-Assembled Monolayers with Mixed Functional Groups. J. Colloid Interface Sci. 2009, 340, 126-130.
50. Joensuu J. J.; Conley A. J.; Brandly J. E.; Linder M. B; Menassa, R. Hydrophobin Fusions for High-Level Transient Protein Expression and Purification in Nicotiana benthamiana. Submitted for publication.
51. Kimura, K.; Takashima, S.; Ohshima, H. Molecular Approach to the Surface Potential Estimate of Thiolate-Modified Gold Nanoparticles. J. Phys. Chem. B 2002, 106, 7260-7266.